BEMA benchmarking scheme for EU drug agencies enters cycle III; medical devices might be on horizon
This article was originally published in Clinica
Executive Summary
A programme to gauge the standards of medicines agencies in the EU and identify opportunities for improving best practices by regulators is beginning a third round of benchmarking exercises. Also, there are early signs that suggest the BEMA programme might in the future cover medical device regulatory activities.